Activated Chicken Gamma Delta T Cells Are Involved in Protective Immunity against Marek’s Disease
Viruses · 2023
DOI: 10.3390/v15020285 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, 2023. Verfasst von Ayumi Matsuyama-Kato und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathobiology, Ontario Veterinary College, University of Guelph, Guelph, ON N1G 2W1, Canada. Hauptthemen laut MEDLINE: Intraepithelial Lymphocytes, Marek Disease, Herpesvirus 2, Gallid. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Biotechnology and Biological Sciences Research Council, Ministry of Agriculture, Food and Rural Affairs, Natural Sciences and Engineering Research Council.
Abstract (Originalsprache)
Gamma delta (γδ) T cells play a significant role in the prevention of viral infection and tumor surveillance in mammals. Although the involvement of γδ T cells in Marek’s disease virus (MDV) infection has been suggested, their detailed contribution to immunity against MDV or the progression of Marek’s disease (MD) remains unknown. In the current study, T cell receptor (TCR)γδ-activated peripheral blood mononuclear cells (PBMCs) were infused into recipient chickens and their effects were examined in the context of tumor formation by MDV and immunity against MDV. We demonstrated that the adoptive transfer of TCRγδ-activated PBMCs reduced virus replication in the lungs and tumor incidence in MDV-challenged chickens. Infusion of TCRγδ-activated PBMCs induced IFN-γ-producing γδ T cells at 10 days post-infection (dpi), and degranulation activity in circulating γδ T cell and CD8α+ γδ T cells at 10 and 21 dpi in MDV-challenged chickens. Additionally, the upregulation of IFN-γ and granzyme A gene expression at 10 dpi was significant in the spleen of the TCRγδ-activated PBMCs-infused and MDV-challenged group compared to the control group. Taken together, our results revealed that TCRγδ stimulation promotes the effector function of chicken γδ T cells, and these effector γδ T cells may be involved in protection against MD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathobiology, Ontario Veterinary College, University of Guelph, Guelph, ON N1G 2W1, Canada.
- Ceva Animal Health Inc., Research Park Centre, Guelph, ON N1G 4T2, Canada.
- Faculty of Veterinary Medicine, University of Calgary, Calgary, AB T2N 1N4, Canada.
- Department of Diagnostic Medicine/Pathobiology, College of Veterinary Medicine, Kansas State University, Manhattan, KS 66506, USA.
- The Pirbright Institute, Pirbright, Woking, Surrey GU24 0NE, UK.
Förderung
- Biotechnology and Biological Sciences Research Council
- Ministry of Agriculture, Food and Rural Affairs
- Natural Sciences and Engineering Research Council
- the University of Guelph’s Food from Thought initiative
- U.K. Research and Innovation Biotechnology and Biological Sciences Research Council
Zitieren
APA
Matsuyama-Kato, A., Shojadoost, B., Boodhoo, N., Raj, S., Alizadeh, M., Fazel, F., Fletcher, C., Zheng, J., Gupta, B., Abdul-Careem, M. F., Plattner, B. L., Behboudi, S., & Sharif, S. (2023). Activated Chicken Gamma Delta T Cells Are Involved in Protective Immunity against Marek’s Disease. Viruses. https://doi.org/10.3390/v15020285
Vancouver
Matsuyama-Kato A, Shojadoost B, Boodhoo N, Raj S, Alizadeh M, Fazel F, et al. Activated Chicken Gamma Delta T Cells Are Involved in Protective Immunity against Marek’s Disease. Viruses. 2023. doi:10.3390/v15020285
BibTeX
@article{MatsuyamaKato2023,
author = {Matsuyama-Kato, Ayumi and Shojadoost, Bahram and Boodhoo, Nitish and Raj, Sugandha and Alizadeh, Mohammadali and Fazel, Fatemeh and Fletcher, Charlotte and Zheng, Jiayu and Gupta, Bhavya and Abdul-Careem, Mohamed Faizal and Plattner, Brandon L and Behboudi, Shahriar and Sharif, Shayan},
title = {Activated Chicken Gamma Delta T Cells Are Involved in Protective Immunity against Marek’s Disease},
journal = {Viruses},
year = {2023},
doi = {10.3390/v15020285}
}
EUVIMED